Drug Type Cytokines, Fusion protein |
Synonyms TGI 17, TGI17 |
Target |
Action modulators |
Mechanism IL2RA modulators(Interleukin-2 receptor alpha chain modulators), PD-1 modulators(Programmed cell death protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 01 Sep 2025 |






